NCI Dictionary of Cancer Terms
The search textbox has an autosuggest feature. When you enter three or more characters, a list of up to 10 suggestions will popup under the textbox. Use the arrow keys to move through the suggestions. To select a suggestion, hit the enter key. Using the escape key closes the listbox and puts you back at the textbox. The radio buttons allow you to toggle between having all search items start with or contain the text you entered in the search box.
polyethylene glycosylated recombinant human megakaryocyte growth and development factor (PAH-lee-EH-thih-leen gly-KAH-sih-lay-ted ree-KOM-bih-nunt HYOO-mun MEH-guh-KAYR-ee-oh-site …)
|A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. Polyethylene glycosylated recombinant human megakaryocyte growth and development factor is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-MGDF and PEG-rhMGDF.|